{"id":785,"date":"2024-05-03T22:12:03","date_gmt":"2024-05-03T22:12:03","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=785"},"modified":"2025-05-03T00:40:04","modified_gmt":"2025-05-03T00:40:04","slug":"biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/de\/durchbruch-bei-biomarkern-wie-das-bevigilant-orafusion-system-die-erkennung-von-mundkrebs-am-behandlungsstuhl-verbessert\/","title":{"rendered":"Biomarker-Durchbruch: Wie das BeVigilant\u2122 OraFusion\u2122-System die Erkennung von Mundkrebs in der Praxis verbessert"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201c1\u2033 _builder_version=\u201c4.16\u2033 lock=\u201coff\u201c global_colors_info=\u201c{}\u201c][et_pb_row _builder_version=\u201c4.16\u2033 background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c global_colors_info=\u201c{ }\u201c][et_pb_column type=\u201c4_4\u2033 _builder_version=\u201c4.16\u2033 custom_padding=\u201c|||\u201c global_colors_info=\u201c{}\u201c custom_padding__hover=\u201c|||\u201c][et_pb_text _builder_version=\u201c4.23.1\u2033 header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding =\u201c25px||||false|false\u201c global_colors_info=\u201c{}\u201c]<\/p>\n<p>Wir sind gespannt <em data-start=\"153\" data-end=\"177\">Bericht zu Dentalprodukten<\/em> Das BeVigilant\u2122 OraFusion\u2122 System wird als bedeutender Fortschritt in der Mundkrebserkennung hervorgehoben. Der Artikel erl\u00e4utert, wie unsere Technologie Speichelbiomarker und KI nutzt, um Echtzeitergebnisse direkt am Behandlungsstuhl zu liefern. So erhalten Zahn\u00e4rzte eine schnelle, nicht-invasive M\u00f6glichkeit, potenziell b\u00f6sartige L\u00e4sionen zu beurteilen. Unser CEO Bill Brodie erl\u00e4utert au\u00dferdem, wie sich unser System in allt\u00e4gliche zahn\u00e4rztliche Arbeitsabl\u00e4ufe integriert und fr\u00fchere, sicherere klinische Entscheidungen bei Erkrankungen wie Leukoplakie und Lichen ruber erm\u00f6glicht. <br \/><a href=\"https:\/\/www.dentalproductsreport.com\/view\/biomarker-reader-helps-catch-oral-cancers-earlier\">Den vollst\u00e4ndigen Artikel finden Sie hier.<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Wir freuen uns, dass der Dental Products Report das BeVigilant\u2122 OraFusion\u2122 System als wichtigen Fortschritt in der Mundh\u00f6hlenkrebserkennung hervorhebt. Der Artikel erl\u00e4utert, wie unsere Technologie Speichelbiomarker und KI nutzt, um Echtzeitergebnisse direkt am Behandlungsstuhl zu liefern. So erhalten Zahn\u00e4rzte eine schnelle, nicht-invasive M\u00f6glichkeit, potenziell b\u00f6sartige L\u00e4sionen zu beurteilen. Au\u00dferdem enth\u00e4lt er Einblicke von unserem CEO, [\u2026]<\/p>","protected":false},"author":9,"featured_media":678,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-785","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/de\/durchbruch-bei-biomarkern-wie-das-bevigilant-orafusion-system-die-erkennung-von-mundkrebs-am-behandlungsstuhl-verbessert\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Patient Resources Understanding the Risk of Oral CancerThe Impact of Oral Cancer In the US alone, oral cancer kills an average one person per hour, 24 hours per day.1Oral cancer is a global challenge with more than 657,000 cases and nearly 330,000 deaths each year1Worldwide 5-year survival rate is only 50% due to delayed intervention [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/de\/durchbruch-bei-biomarkern-wie-das-bevigilant-orafusion-system-die-erkennung-von-mundkrebs-am-behandlungsstuhl-verbessert\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-03T22:12:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-03T00:40:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/Orafusion-System-1-1024x737.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"737\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Rachel LaBreck\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rachel LaBreck\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/\"},\"author\":{\"name\":\"Rachel LaBreck\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753\"},\"headline\":\"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection\",\"datePublished\":\"2024-05-03T22:12:03+00:00\",\"dateModified\":\"2025-05-03T00:40:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/\"},\"wordCount\":186,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/\",\"name\":\"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2024-05-03T22:12:03+00:00\",\"dateModified\":\"2025-05-03T00:40:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753\",\"name\":\"Rachel LaBreck\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g\",\"caption\":\"Rachel LaBreck\"},\"url\":\"https:\/\/vigilantbiosciences.com\/de\/author\/rachel-labreck\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection - Vigilant Biosciences\u00ae","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/de\/durchbruch-bei-biomarkern-wie-das-bevigilant-orafusion-system-die-erkennung-von-mundkrebs-am-behandlungsstuhl-verbessert\/","og_locale":"de_DE","og_type":"article","og_title":"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection - Vigilant Biosciences\u00ae","og_description":"Patient Resources Understanding the Risk of Oral CancerThe Impact of Oral Cancer In the US alone, oral cancer kills an average one person per hour, 24 hours per day.1Oral cancer is a global challenge with more than 657,000 cases and nearly 330,000 deaths each year1Worldwide 5-year survival rate is only 50% due to delayed intervention [&hellip;]","og_url":"https:\/\/vigilantbiosciences.com\/de\/durchbruch-bei-biomarkern-wie-das-bevigilant-orafusion-system-die-erkennung-von-mundkrebs-am-behandlungsstuhl-verbessert\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2024-05-03T22:12:03+00:00","article_modified_time":"2025-05-03T00:40:04+00:00","og_image":[{"width":1024,"height":737,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/Orafusion-System-1-1024x737.png","type":"image\/png"}],"author":"Rachel LaBreck","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Rachel LaBreck","Gesch\u00e4tzte Lesezeit":"1 Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/"},"author":{"name":"Rachel LaBreck","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753"},"headline":"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection","datePublished":"2024-05-03T22:12:03+00:00","dateModified":"2025-05-03T00:40:04+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/"},"wordCount":186,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/","url":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/","name":"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2024-05-03T22:12:03+00:00","dateModified":"2025-05-03T00:40:04+00:00","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/biomarker-breakthrough-how-the-bevigilant-orafusion-system-enhances-chairside-oral-cancer-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"Biomarker Breakthrough: How the BeVigilant\u2122 OraFusion\u2122 System Enhances Chairside Oral Cancer Detection"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753","name":"Rachel LaBreck","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g","caption":"Rachel LaBreck"},"url":"https:\/\/vigilantbiosciences.com\/de\/author\/rachel-labreck\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/comments?post=785"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/785\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media\/678"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media?parent=785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/categories?post=785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/tags?post=785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}